Oxidative stress and antioxidant status in rotenone induced rat models of Parkinson’s disease

Suchitra Kavuri (1) , Senthilkumar Sivanesan (2) , Vijayaraghavan Rajagopalan (3)
(1) Department of Biochemistry, Alluri Sitarama Raju Academy of Medical Sciences, Eluru-534005, Andhra Pradesh, India, India ,
(2) Department of Research and Development, Saveetha Institute of Medical and Technical Sciences, Chennai-602105, Tamil Nadu, India, India ,
(3) Department of Research and Development, Saveetha Institute of Medical and Technical Sciences, Chennai-602105, Tamil Nadu, India, India

Abstract

Parkinson disease (PD) is involved in the damage of neurons of the brain that secretes dopamine. Understanding the mechanisms involved in Parkinson's disease helps to develop effective management methods. Hence, the present work aimed to unravel the variations, if any, in the parameters of oxidative stress and antioxidant markers between oral and ip rotenone-induced rat model of Parkinson’s disease. Male Wistar rats weighing between 250-300g were housed in solid bottomed polypropylene cages under strict veterinary supervision and maintained in rooms with 12hrs light / dark cycle. The randomly selected male Wistar rats were equally divided into four groups, with six rats in each group. The study results provide scientific evidence for marked changes in both the oxidative and antioxidant parameters, followed by the ip or po rotenone administration. It is the need of the time to consider the neuroprotective and antioxidant properties while developing the newer treatment modalities for the management of PD.

Full text article

Generated from XML file

References

Anderson, G., Maes, M. 2014. Neurodegeneration in Parkinson’s Disease: Interactions of Oxidative Stress, Tryptophan Catabolites and Depression with Mitochondria and Sirtuins. Molecular Neurobiology, 49(2):771–783.

Birben, E., Sahiner, U.M., Sackesen, C., Erzurum, S., Kalayci, O. 2012. Oxidative Stress and Antioxidant Defense. World Allergy Organization Journal, 5(1):9–19.

Caviness, J.N., Lue, L., Adler, C.H., Walker, D.G. 2011. Parkinson’s Disease Dementia and Potential Therapeutic Strategies. CNS Neuroscience & Therapeutics, 17(1):32–44.

Dalfó, E., Portero-Otín, M., Ayala, V., Martínez, A., Pamplona, R., Ferrer, I. 2005. Evidence of Oxidative Stress in the Neocortex in Incidental Lewy Body Disease. Journal of Neuropathology & Experimental Neurology, 64(9):816–830.

Gaballah, H.H., Zakaria, S.S., Elbatsh, M.M., Tahoon, N.M. 2016. Modulatory effects of resveratrol on endoplasmic reticulum stress-associated apoptosis and oxido-inflammatory markers in a rat model of rotenone-induced Parkinson’s disease. Chemico-Biological Interactions, 251:10–16.

Haleagrahara, N., Ponnusamy, K. 2010. Neuro-protective effect of Centella asiatica extract (CAE) on experimentally induced parkinsonism in aged Sprague-Dawley rats. The Journal of Toxicological Sciences, 35(1):41–47.

Hassanzadeh, K., Rahimmi, A. 2019. Oxidative stress and neuroinflammation in the story of Parkinson’s disease: Could targeting these pathways write a good ending. Journal of Cellular Physiology, 234(1):23–32.

Henze, C., Earl, C., Sautter, J., Schmidt, N., Themann, C., Hartmann, A., Oertel, W. H. 2005. Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats. Brain Research, 1052(1):97–104.

Jimenez-Jimenez, F.J., Alonso-Navarro, H., Garcã a- Martã n, E., Agãondez, J.A.G. 2014. Cerebrospinal fluid biochemical studies in patients with Parkinson’s disease: toward a potential search for biomarkers for this disease. Frontiers in Cellular Neuroscience, 8(369).

Johnson, W.M., Wilson-Delfosse, A.L., Mieyal, J.J. 2012. Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases. Nutrients, 4(10):1399–1440.

Khan, M.M., Ahmad, A., Ishrat, T., Khan, M.B., Hoda, M.N., Khuwaja, G., Islam, F. 2010. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson’s disease. Brain Research, 1328:139– 151.

Levine, R.L., Garland, D., Oliver, C.N., Amici, A., Climent, I., Lenz, A.G., Stadtman, E.R. 1990. Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology, pages 464–478.

Moron, M., Depierre, J., Mannervik, B. 1979. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et Biophysica Acta (BBA)-General Subjects, 582(1):90289–90296.

Niedzielska, E., Smaga, I., Gawlik, M., Moniczewski, A., Stankowicz, P., Pera, J., Filip, M. 2016. Oxidative Stress in Neurodegenerative Diseases. Molecular Neurobiology, 53(6):4094–4125.

Rajagopalan, A., Jinu, K., Sailesh, K., Mishra, S., Reddy, U., Mukkadan, J. 2017. Understanding the links between vestibular and limbic systems regulating emotions. Journal of Natural Science Biology and Medicine, 8(1):11–11.

Rotruck, J. T., Pope, A.L., Ganther, H.E., Swanson, A.B., Hafeman, D.G., Hoekstra, W.G. 1973. Selenium: Biochemical Role as a Component of Glutathione Peroxidase. Science, 179(4073):588–590.

Sailesh, K.S., Archana, R. 2019. Effect of caloric vestibular stimulation on brain neurotransmitters in an MPTP-induced mouse model of Parkinson’s disease. International Journal of Research in Pharmaceutical Sciences, 10(1):40–44.

Sinha, A.K. 1972. Colorimetric assay of catalase. Analytical Biochemistry, 47(2):90132–90139.

Wills, E. 1966. Mechanisms of lipid peroxide formation in animal tissues. Biochemical Journal, 99(3):667–676.

Authors

Suchitra Kavuri
suchikavuri@gmail.com (Primary Contact)
Senthilkumar Sivanesan
Vijayaraghavan Rajagopalan
Suchitra Kavuri, Senthilkumar Sivanesan, & Vijayaraghavan Rajagopalan. (2020). Oxidative stress and antioxidant status in rotenone induced rat models of Parkinson’s disease. International Journal of Research in Pharmaceutical Sciences, 11(1), 1–6. Retrieved from https://ijrps.com/home/article/view/361

Article Details

Most read articles by the same author(s)

No Related Submission Found